SCHEMBL6922909

SCHEMBL6922909

Cc1nc2cc(C(=O)O)ccc2c(=O)n1C

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HTT P42858 1/20 0.48
AKR1B1 P15121 1/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 3/20 0.45
RECQL P46063 1/20 0.45
HCAR3 P49019 1/20 0.44
GLA P06280 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2119122 0.84 HDAC6 (0.49)
SCHEMBL2118762 0.84 ALDH1A1 (0.55) HSD17B10TDP1HTTMEN1KMT2A
SCHEMBL9919081 0.80 MEN1 (0.40) MAPK1HSD17B10TDP1MEN1KMT2A
SCHEMBL554569 0.80 HSD17B10 (0.64) HSD17B10TDP1HTTMEN1KMT2A
SCHEMBL19359658 0.80 ESR1 (0.54) HSD17B10AKR1B1KMT2AKDM4EMAPT
SCHEMBL5986479 0.79 CYP3A4 (0.48) TDP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL15840322 0.76 L3MBTL1 (0.49) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL1161500 0.76 CASP3 (0.43) MAPK1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL18247596 0.76 TDP1 (0.53) HSD17B10TDP1HTTMEN1KMT2A
SCHEMBL8845824 0.76 KMT2A (0.57) MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed